Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015

Tumor necrosis factor-α (TNF-α) inhibitors are increasingly being used as treatment for rheumatoid arthritis (RA). However, the administration of these drugs carries the risk of inducing injection site reaction (ISR). ISR gives rise to patient stress, nervousness, and a decrease in quality of life (...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsui, Toshinobu, Umetsu, Ryogo, Kato, Yamato, Hane, Yuuki, Sasaoka, Sayaka, Motooka, Yumi, Hatahira, Haruna, Abe, Junko, Fukuda, Akiho, Naganuma, Misa, Kinosada, Yasutomi, Nakamura, Mitsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332837/
https://www.ncbi.nlm.nih.gov/pubmed/28260984
http://dx.doi.org/10.7150/ijms.17025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332837/
https://www.ncbi.nlm.nih.gov/pubmed/28260984
http://dx.doi.org/10.7150/ijms.17025

Ejemplares similares